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Abstract
We present a case of a 62-year-old man who underwent total hip arthroplasty for treatment of pathologic femoral
neck fracture associated with adefovir dipivoxil-induced osteomalacia. He had a 13-month history of bone pain
involving his shoulders, hips, and knee. He received adefovir dipivoxil for treatment of lamivudine-resistant hepatitis
B virus infection for 5 years before the occurrence of femoral neck fracture. Orthopedic surgeons should be aware
of osteomalacia and pathological hip fracture caused by drug-induced renal dysfunction, which results in Fanconi’s
syndrome.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1600344696739249
Keywords: Osteomalacia, Pathological femoral neck fracture, Adefovir dipivoxil, Hepatitis B, Fanconi’s syndrome
Background
Hypophosphatemic osteomalacia caused by proximal
renal tubule dysfunction induces Fanconi’s syndrome,
which leads to impaired reabsorption of amino acids, glu-
cose, urate, and phosphate [1]. The chronic loss of phos-
phate and impaired synthesis of 1,25-dihydroxyvitamin D3
may lead to failure of bone mineralization. Recently,
osteomalacia was reported in cases in which hepatitis B
virus and human immunodeficiency virus (HIV) infections
were treated using high-dose adefovir dipivoxil [2-6]. We
report a case of a patient who underwent total hip arthro-
plasty for pathological femoral neck fracture associated
with osteomalacia induced by low-dose adefovir dipivoxil
treatment.
Case presentation
A 62-year-old man started experiencing pain in the right
knee and left shoulder pain in January 2010. He visited
a clinic and was administered salazosulfapyridine and
methylprednisolone therapy for rheumatoid arthritis.
However, the pain gradually increased, and he started ex-
periencing pain in his hip joints as well. Therefore, he was
admitted our hospital for further examination in February
2011. He had a 7-year history of chronic hepatitis caused
by hepatitis B virus infection, and had received lamivudine
therapy for 2 years. Because the virus developed resistance
to lamivudine, he received adefovir dipivoxil for 5 years
before the development of the femoral neck fracture. After
adefovir dipivoxil treatment, his liver function was
restored. Radiography showed femoral neck fractures
(right, Garden III fracture; left, Garden IV fracture) and a
distal right tibial fracture (Figure 1a) [7]. Magnetic reson-
ance imaging (MRI) of both hip joints showed fractures
across the right and left femoral neck and bone edema,
which had low intensity on T1-weighted images and
high intensity on T2-weighted images (Figure 1b).
99mTc-hydroxymethylene diphosphonate (HMDP) whole-
body bone scintigraphy showed increased uptake of the
radiotracer in the calvaria, maxilla, both scapulae, ribs,
both femoral necks, right condyle of the femur, right tibia,
and both tarsi (Figure 1c). He showed hypophosphatemia
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(2.0 mg/dL; normal range, 2.5–4.5 mg/dL) and increased
levels of alkaline phosphatase (ALP, 1594 IU/L; normal
range, 115–359 IU/L). Furthermore, he showed normal
serum creatinine (0.7 mg/dL; normal range, 0.4–0.7 mg/dL),
blood urea nitrogen (BUN, 12.3 mg/dL; normal range,
8.0–22.0 mg/dL), intact parathyroid hormone (PTH,
19 pg/mL; normal range, 10–65 pg/mL), and 1,25-
dihydroxyvitamin D3 (40.0 pg/mL; normal range, 20–
60 pg/mL) levels. Urinalysis revealed proteinuria. A 24-h
study showed increased urinary excretion of phosphate
(1004 mg/day; normal range, 70–220 mg/day), cal-
cium (471.0 mg/day; normal range, 100–300 mg/day),
N-acetylglucosaminidase (11.8 U/L; normal range,
<7.0 U/L), and β2-microglobulin (64,579 μg/L; nor-
mal range, 230 μg/L). These findings indicated hypo-
phosphatemia and hyperphosphaturia (increased levels
of ALP). However, because the patient had normal
levels of 1,25-dihydroxyvitamin D3, we considered
that the impaired phosphate reabsorption could have been
caused by dysfunction of the proximal renal tubule dys-
function and not by deficiency of vitamin D. Urinalysis
and examination of urine samples collected over 24 h
showed increased levels of N-acetylglucosaminidase and
β2-microglobulin as well as phosphate wasting, which also
indicated that these symptoms were caused by dysfunction
of the proximal renal tubule.
On the basis of these findings, we made a diagnosis of
osteomalacia and pathologic fractures due to Fanconi’s
syndrome secondary to adefovir therapy (10 mg/day). We
conducted preoperative examinations to perform total hip
arthroplasty. Prolonged bleeding time was observed by
platelet aggregation failure and coagulation factor defi-
ciency (Table 1). The coagulation disorder was suggested
to have been caused by chronic hepatitis. The bleeding
time was normalized by platelet transfusion. or double-
labeling analysis, 1000 mg of tetracycline was orally
Figure 1 Imaging studies. a: Plain radiographs of both femurs reveal femoral neck fractures. (right, Garden III fracture; left, Garden IV fracture)
b: Coronal T1-weighted image demonstrates low-intensity femoral neck fractures and the T2-weighted image shows high-intensity bone edema.
c: 99mTc-hydroxymethylene diphosphonate (HMDP) scintigraphy demonstrates significant abnormal uptake in calvaria, maxilla, both scapulae, ribs,
both femoral necks, right condyle of the femur, right tibia, and both tarsi. d: Plain radiographs of hip joints in which total hip arthroplasty was
performed by inserting an implant in the left hip joint.
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administered at 10-day intervals. A 2-step procedure was
performed under the same general anesthetic. During the
first part of the procedure, biopsy of the iliac bone was
performed, and during the second stage of the procedure,
total hip arthroplasty was performed using a Zimmer im-
plant (cemented collarless polished taper. stem, cement-
less trabecular metal modular acetabular cup, 36-mm
head; Figure 1d). Because the acetabular roof bone was
too fragile to support the acetabular components, bone
fragment autografts prepared from the left femoral head
were transplanted at the acetabular roof. The patient
received intravenous antibiotics for 3 days. On the first
postoperative day, the patient began rehabilitation under
the supervision of a physiotherapist. He began using
crutches for ambulation on postoperative day 7, with pro-
gressive weight-bearing as tolerated. The time to full
weight-bearing was 3 weeks after the operation. The iliac
bone and femoral head samples were fixed and stained
using Villanueva bone stain and Villanueva–Goldner
counterstain. The osteoid volume/mineralized bone vol-
ume ratio was 20.7% (average, <10%) and osteoid thick-
ness was 25.1 μm (average, <12.5 μm; Figure 2a).
Examination using tetracycline labeling showed no
double-labeling pattern (Figure 2b) [8]. These findings
confirmed that the pathological fractures were caused by
osteomalacia (reviewed in [8]). After surgery, adefovir
dipivoxil was switched with entecavir hydrate, and eldecal-
citol and alendronate sodium hydrate were administered.
These treatments normalized the blood phosphate level.
The Japanese Orthopaedic Association Hip Score for the
hip joints was 73 points at 2 months after surgery. He did
not show any new pathological fractures.
Discussion
Adefovir dipivoxil is a commonly used antiviral agent
in the treatment of chronic hepatitis B or HIV infection
[9]. Fanconi’s syndrome has been recognized as a
Table 1 Title: coagulation factors
Activity Normal range
Coagulation factor II 46.6% (66.0–118.0)
Coagulation factor III 65.1% (73.0–122.0)
Coagulation factor VII 65.6% (54.0–162.0)
Coagulation factor VIII 89.8% (78.0–165.0)
Coagulation factor IX 43.5% (67.0–152.0)
Coagulation factor X 54.3% (58.0–200.0)
Coagulation factor XI 43.5% (75.0–137.0)
Von Willebrand factor 200% (50.0–150.0)
Figure 2 Pathological examinations. a: Mineralized bone tissues are colored in green and nonmineralized osteoid tissues are shown in orange
by Villanueva-Goldner stain. Mineralized bone tissues are colored in purple and nonmineralized osteoid tissues are shown in the clear zone by
Villanueva bone stain. The osteoids volume/mineralized bone volume ratio was 20.7% (normal range, less than 10%). Osteoid thickness was
25.1 μm (average, less than 12.5 μm). b: Tetracycline labeling examination showed no double-labeling pattern. These findings indicate
mineralization deficiency and osteomalacia.
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complication of high-dose adefovir dipivoxil therapy
(dose, 60–120 mg/day) in the treatment of HIV infec-
tion [10]. Few studies have reported severe hypopho-
sphatemia with 10 mg/day adefovir dipivoxil therapy
[11-14]. In addition, to our knowledge, this is the first
report of pathological femoral neck fracture associated
with adefovir dipivoxil-induced osteomalacia treated by
total hip arthroplasty. When orthopaedic surgeons en-
counter adefovir dipivoxil–treated chronic hepatitis B
patients with pathological hip fractures, the patients’
renal function and levels of electrolytes, including cal-
cium and phosphorus, should be carefully monitored.
Fanconi’s syndrome results from dysfunction of the
proximal renal tubule, causing impaired reabsorption of
amino acids, urate, bicarbonate, and phosphate and
increased excretion of these solutes into the urine. The
pathophysiology of proximal renal tubule dysfunction is
thought to be an increase in the adefovir dipivoxil concen-
tration in the mitochondria mediated by inhibition of sev-
eral ATP-dependent transporters [15,16]. Patients with
Fanconi’s syndrome show low phosphate levels (because
of renal phosphate loss) and normal levels of calcium,
25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and
PTH and increased ALP levels. Radiography and bone scan
showed multiple patterns of osteomalacia. Our findings
were consistent with those in previous reports [17].
Entecavir is more effective than adefovir dipivoxil, with
a favorable safety profile and low incidence of resistance
[18]. We switched adefovir dipivoxil with entecavir hy-
drate as previously reported [19,20]. Entecavir may be a
good treatment choice. In addition to adefovir dipivoxil,
the patient received oral administration of lamivudine,
rebamipide, rabeprazole sodium, and methylpredniso-
lone. These drugs may have caused Fanconi’s syndrome.
After the patient’s condition was diagnosed as Fanconi’s
syndrome, adefovir dipivoxil was replaced with entecavir
hydrate. Thereafter, the symptoms of Fanconi’s syn-
drome improved. These findings suggested that adefovir
dipivoxil caused Fanconi’s syndrome and osteomalacia.
In conclusion, orthopaedic surgeons should be aware
of osteomalacia and pathologic fractures caused by ade-
fovir dipivoxil administered as anti-hepatitis B virus ther-
apy. In addition to the above-mentioned antiviral agent,
ifosfamide, valproic acid, aminoglycosides, methyl-3-
chromone, paraquat, L-lysine, calcineurin-inhibitor, or
tetracycline may cause hypophosphatemic osteomalacia;
therefore, serum ALP and phosphorus levels of patients
receiving these drugs should be monitored [21-28].
Consent
Written informed consent was obtained from the patient
and his family for publication of this case report. A copy
of the written consent is available for review by the
Editor-in-Chief of the journal.
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